# Biodexa Pharmaceuticals Plc: Form 6-K, filed Oct 3, 2023

- Company: [Biodexa Pharmaceuticals Plc](/companies/bdrx.md) (CIK 1643918)
- Form: 6-K
- Filed: 2023-10-03
- Accepted by EDGAR: Oct 3, 2023, 10:10 ET
- Period: 2023-10-03
- Accession: 0001171843-23-006004
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1643918/000117184323006004/f6k_100323.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1643918/000117184323006004/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1643918/000117184323006004/f6k_100323.htm

Filed Oct 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-006004. Last ingested by Listed: Nov 9, 2026, 17:57 ET. No prices; not investment advice.
